对轻度认知障碍进展者和非进展者的语义性能进行了检查
Emilie Delage1, Isabelle Rouleau1, Marc-Antoine Akzam-Ouellette1
1Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal.
Neuropsychology
|February 15, 2024
概括
具有轻度认知障碍 (MCI) 的个人,表现出语义缺陷,患阿尔茨海默病 (AD) 进展的风险更高. 在MCI中早期识别语义障碍可能预测未来对AD的下降.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 认知心理学 认知心理学
背景情况:
- 轻度认知障碍 (MCI) 是阿尔茨海默病 (AD) 的重要危险因素,大约50%的人在五年内进展.
- 了解MCI进展的预测因素对于早期干预和疾病管理至关重要.
研究的目的:
- 为了比较患有MCI而进展为AD (MCI-p) 的个体与保持稳定的个体 (MCI-np) 的语义表现.
- 调查基线语义缺陷是否预测未来的认知衰退和发展为阿尔茨海默病.
主要方法:
- 来自阿尔茨海默氏症早期识别联盟-北克研究的56名参与者 (65-89岁) 的分析.
- 在2年的时间内,参与者分为MCI进展者 (n=18) 和非进展者 (n=38) 的分类.
- 使用ANCOVA评估最初的语义和非语义认知表现,使用重复测量ANOVA评估纵向认知下降.
主要成果:
- 与MCI非进展者相比,MCI进展者在语义测试 (类别流性,对象决策) 上表现明显较差.
- 患有MCI进展者在执行功能 (认知灵活性) 中也有缺陷,但在基线时没有出现情节性记忆.
- 虽然语义测试进展率没有差异,但MCI进展者在随访时在全球认知,情节性记忆和处理速度方面表现出更为急剧的下降.
结论:
- 语义记忆障碍,特别是当与情节性记忆缺陷同时发生时,与从MCI发展为阿尔茨海默病的风险增加有关.
- 这些发现凸显了语义性能作为MCI患者阿尔茨海默病风险早期指标的潜力.
更多相关视频
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
32.3K
11:01Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease
Published on: August 30, 2011
13.6K
相关概念视频
Cognitive Development During Adulthood
109
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
109
Alzheimer's Disease: Overview
484
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
484
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
125
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
125
Negative and Cognitive Symptoms of Schizophrenia
48
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
48
